1 %The Pfcrt haplotype CVIET decreased to 1% in 2017 in Kenya.
Kenyapaludismeobservé 2017publié 2025Malaria journalPubMeddocument de 14 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 713 evidences · page 9 / 69
1 %The Pfcrt haplotype CVIET decreased to 1% in 2017 in Kenya.
Kenyapaludismeobservé 2017publié 2025Malaria journalPubMeddocument de 14 observations
Mild-to-moderate hypercalcemia was common at admission, particularly among children with severe anemia.
Kenyapaludismepublié 2005Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument de 4 observationsDOI 10.1086/426022
70 per_100Sub-counties in the north of the lake-endemic region exhibited the highest population-weighted malaria test positivity rates, with exceedance probability > 70% with 90% certainty.
Kenyapaludismeobservé 2018-2019publié 2021Malaria journaleurope_pmcdocument de 4 observations
25 %The median Plasmodium falciparum PCR-positive prevalence (PCRpfPR) among children aged 7 months to 10 years was 25% in the intervention arm after 5 months.
Kenyapaludismepublié 2021The American journal of tropical medicine and hygienePubMeddocument de 10 observations
15 %In the moderate and high malaria risk strata, intermittent preventive therapies for school children in addition to existing vector control was predicted to reduce incidence by an additional 15%.
Kenyapaludismepublié 2022Malaria journaleurope_pmcdocument de 4 observationsDOI 10.1186/s12936-022-04099-5
0,9 %The A675V mutation was absent in 2019 and increased from 0.9% in 2022 to 5% in 2023.
Kenyapaludismeobservé 2022publié 2025Scientific reportsPubMeddocument de 6 observations
39 %Plasmodium falciparum parasite prevalence by qPCR rose to 39% among 90 adults on day 84.
Kenyapaludismepublié 2020Comparing drug regimens for clearance of malaria parasites in asymptomatic adults using PCeurope_pmcdocument de 4 observations
24 %Almost a quarter of patients (24%) admitted with a malaria diagnosis had a reported comorbidity.
Kenyapaludismeobservé June 2016 to May 2017publié 2021Malaria journalPubMeddocument de 11 observations
4,7 %In the PERCH study, the prevalence of malaria parasitaemia was 4.7% among WHO pneumonia cases.
Kenyapaludismepublié 2025International journal of epidemiologyeurope_pmcdocument de 8 observations
1,2 per_1000The mean incidence of Plasmodium falciparum in 2009 was 1.2 cases per 1000 population.
Kenyapaludismeobservé 2009publié 2014PloS oneeurope_pmcdocument de 7 observations
0 prevalence_differenceThe adjusted site-specific prevalence difference for spontaneous abortion among Kenyan women with first-trimester malaria was 0.00.
Kenyapaludisme · spontaneous abortionpublié 2024PloS onePubMeddocument de 14 observations
6 %Babies born to primigravidae who received Maloprim had 6% low birth weight compared to 22% in those who received placebo.
Kenyapaludismepublié 1989Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 7 observations
92,2 %The positive predictive value of microscopy for detecting P. falciparum parasitaemia was 92.2% in asymptomatic children aged 7–14 years in western Kenya.
Kenyapaludismepublié 2022Malaria journalPubMeddocument de 6 observations
5,6 %Sporozoite prevalence was 5.6% in Anopheles funestus.
Kenyapaludismeobservé 2020publié 2022Parasites & vectorsPubMeddocument de 6 observations
178 600 000 inhabitantsIn 2000, 178.6 million (28.1%) people lived in areas of mesoendemic transmission (>10% to 50% PfPR2-10) in Africa.
Kenyapaludismeobservé 2000publié 2014Lancet (London, England)europe_pmcdocument de 4 observations
There was a significant difference in probability of non-infection during malaria episodes in the study sites, with Kombewa having the least median time of non-infection during malaria episodes.
Kenyapaludismepublié 2022Parasites & vectorsPubMeddocument de 7 observations
100 %Wild Anopheles gambiae sensu lato (s.l.) and Anopheles funestus s.l. showed 100% susceptibility to broflanilide.
Kenyapaludismepublié 2025Malaria journalPubMeddocument de 6 observations
In the field study, immature and adult Anopheles mosquito populations were significantly lower in the intervention village compared to the control village during the larviciding period.
KenyaAnopheles · paludismeobservé larviciding periodpublié 2020Malaria journalPubMeddocument de 4 observations
There were no re-infections observed during the stated 28-day follow-up period.
Kenyapaludismeobservé 2015publié 2021Epidemiology and infectionPubMeddocument de 5 observations
7,8 %7.8% (53/683) of tested mosquito abdomens were positive for Plasmodium falciparum.
Kenyapaludismepublié 2024Parasites & vectorsPubMeddocument de 5 observations
3 000 000 000 peopleMore than 3 billion people were at risk of malaria in 2005.
Kenyapaludismeobservé 2005publié 2006Advances in parasitologyeurope_pmcDOI 10.1016/s0065-308x(05)62005-2
49 %Among children aged 3-59 months who received malaria chemoprophylaxis from a village health worker in addition to treatment, there was a 49% reduction in mortality.
Kenyapaludismepublié 1990Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 2 observations
31 %Malaria test positivity rate (TPR) among febrile admissions aged 1 month to 14 years at Tororo district hospital was 31% during the final period of Actellic IRS and LLIN (June 2016–December 2019).
Kenyapaludismeobservé June 2016–December 2019publié 2020Malaria journaleurope_pmcdocument de 4 observationsDOI 10.1186/s12936-020-03490-4
100 000 000 inhabitants0.10 billion people at risk of Plasmodium vivax transmission were located in the Africa+ region in 2009, representing 3.5% of the total population at risk.
Kenyapaludismeobservé 2009publié 2010PLoS neglected tropical diseaseseurope_pmcdocument de 5 observationsDOI 10.1371/journal.pntd.0000774
1 526 participantsA total of 1526 and 1546 participants from two consecutive, 12-month cohorts were assessed for first-time malaria infection.
Kenyapaludismepublié 2025Lancet (London, England)PubMeddocument de 4 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.